"Hyperuricemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
Descriptor ID |
D033461
|
MeSH Number(s) |
C23.550.449
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperuricemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperuricemia".
This graph shows the total number of publications written about "Hyperuricemia" by people in this website by year, and whether "Hyperuricemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperuricemia" by people in Profiles.
-
Is It Time to Start Treating Asymptomatic Hyperuricemia? Am J Kidney Dis. 2015 Dec; 66(6):933-5.
-
Patient and clinical characteristics associated with gout flares in an integrated healthcare system. Rheumatol Int. 2015 Nov; 35(11):1799-807.
-
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response. Clin Pharmacol Ther. 2015 May; 97(5):518-25.
-
Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia. J Rheumatol. 2014 May; 41(5):955-62.
-
Metabolic abnormalities are present in adults with elevated serum cystatin C. Kidney Int. 2009 Jul; 76(1):81-8.